Phenotypic Improvement of Dystrophic Muscles by rAAV/Microdystrophin Vectors Is Augmented by Igf1 Codelivery

This publication has 42 references indexed in Scilit:

• AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype
  Molecular Therapy, 2004
• Functional correction of adult mdx mouse muscle using gutted adenoviral vectors expressing full-length dystrophin
  Proceedings of the National Academy of Sciences, 2002
• Adeno-Associated Virus Vector-Mediated Minidystrophin Gene Therapy Improves Dystrophic Muscle Contractile Function inmdxMice
  Human Gene Therapy, 2002
• Micro-dystrophin cDNA ameliorates dystrophic phenotypes when introduced into mdx mice as a transgene
  Biochemical and Biophysical Research Communications, 2002
• Modular flexibility of dystrophin: Implications for gene therapy of Duchenne muscular dystrophy
  Nature Medicine, 2002
• Dystrophin Expression in Muscle Following Gene Transfer with a Fully Deleted ("Gutted") Adenovirus Is Markedly Improved by Trans-Acting Adenoviral Gene Products
  Human Gene Therapy, 2001
• Tibialis anterior muscles in mdx mice are highly susceptible to contraction-induced injury
  Journal of Muscle Research and Cell Motility, 2001
• Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model
  Proceedings of the National Academy of Sciences, 2000
• Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals
  Cell, 1987
• Regeneration of single skeletal muscle fibers in vitro
  The Anatomical Record, 1975